Clinical Trial Update: Study of Sequential CAR-T Cell Treating Leukemia Children [Phase 2]

View source ↗

Summary

A Phase 2 trial of sequential CAR-T cell therapy for pediatric acute lymphoblastic leukemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• CAR-T cell therapy (sequential) (CAR-T cell therapy)

Snippet

Sponsor: Beijing Boren Hospital | Conditions: Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse | Phase 2 | Status: TERMINATED